Merck’s Covid Pill Approved in the UK
By Radiant HealthPublished: November 6, 2021

Merck achieved something unprecedented when the United Kingdom announced that it was authorizing the company’s antiviral pill to be used on Covid-19 patients. The drug will be made available to patients who experience Covid-19 symptoms and have at least one risk factor like heart disease, obesity, or are over the age of 60. The UK concurred that the pill is safe and effective and decreases deaths and hospitalizations. The therapeutic, molnupiravir, can be taken at home in the first few days after symptoms appear.
Like what you're reading? Sign up for our free newsletter and never miss a post! Plus get a FREE digital version of our Issue No.10 with sign up.

- Pfizer’s Antiviral Pill is Very Effective - May 15, 2022
- Spain Considers Three Days Off for Menstrual Pain - May 15, 2022
- Moderna Requests Approval for its Children’s Vaccine - May 15, 2022
- Routine Colonoscopies Should Start at Age 45 - May 15, 2022
- Anti-inflammatory Drugs May Do More Harm Than Good - May 15, 2022
- Some People Die from a Happy Heart - May 8, 2022
- Johnson & Johnson Vaccine Can Cause Serious Blood Clots - May 8, 2022
- Omicron Variants Spreading Quickly - May 8, 2022
- Roe V. Wade Will Likely Be Overturned - May 8, 2022
- Menthol Cigarette Ban Will Benefit the Black Community - April 30, 2022